Extended release erythromycin derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 31/7048 (2006.01) A61K 47/02 (2006.01) A61K 47/10 (2006.01) A61K 47/14 (2006.01) C07H 17/08 (2006.01)

Patent

CA 2425688

An extended release pharmaceutical composition comprised of an erythromycin derivative and non-polymer material for providing for extended release, in particular, a member selected from the group consisting of clays, long chain hydrocarbons, long chain carboxylic acids, long chain carboxylic acid esters, long chain alcohols, and mixtures thereof, with said member being present in an amount to provide for extended release of the erythromycin derivative.

La présente invention concerne une composition pharmaceutique constituée d'un dérivé d'érythromycine et d'un matériau non polymère assurant la libération prolongée, plus particulièrement un élément sélectionné dans le groupe formé par les argiles, les hydrocarbures à longue chaîne, les acides carboxyliques à longue chaîne, les esters d'acide carboxylique à longue chaîne, les alcools à longue chaîne et les mélanges de ces derniers; ledit élément étant présent suivant une quantité suffisante pour assurer la libération prolongée du dérivé d'érythromycine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Extended release erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extended release erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release erythromycin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1480148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.